Table 2

Demographics and comorbidities of incident valve disease

No valve disease
(N=472 328)
Any valve disease
(N=13 615)
Mitral valve prolapse
(N=1119)
Mitral regurgitation
(N=6900)
Mitral stenosis
(N=2095)
Aortic regurgitation
(N=4238)
Aortic stenosis
(N=6020)
Tricuspid regurgitation
(N=1664)
Female, n (%)259 071 (55)5980 (44)497 (44)3242 (47)1107 (3)1829 (43)2443 (41)822 (49)
BMI >30 kg/m2, n (%)114 072 (24)4418 (33)144 (13)1969 (27)557 (27)1320 (31)2228 (37)561 (34)
SBP (mmHg)140±20145±21141±20144±21143±21145±21147±21144±21
Smoking (%)6722 (1)513 (4)26 (2)207 (3)15 (1)94 (2)205 (3)86 (5)
Dyslipidaemia, n(%)9958 (2)1855 (14)105 (9)794 (11.5)47 (2.2)360 (8.5)776 (12.9)222 (13.3)
Diabetes, n (%)9564 (2.0)1527 (11.2)37 (3.3)590 (8.6)40 (1.9)225 (5.3)735 (12.2)229 (13.8)
CAD, n (%)4491 (1.0)2069 (15.2)119 (10.6)911 (13.2)51 (2.4)417 (9.8)883 (14.7)202 (12.1)
CHF, n (%)1545 (0.3)1801 (13.2)68 (6.1)1098 (15.9)99 (4.7)254 (6.0)430 (7.1)395 (23.7)
Rheumatic fever, n(%)30 (0.0)891 (6.5)32 (2.9)836 (12.1)927 (44.3)146 (3.5)130 (2.2)214 (12.9)
Infective endocarditis, n (%)105 (0.0)974 (7.2)52 (4.7)902 (13.1)932 (44.5)155 (3.7)125 (2.1)225 (13.5)
Atrial fibrillation and flutter, n (%)3965 (0.8)3840 (28.2)271 (24.2)2867 (41.6)1022 (48.8)1694 (40.0)2002 (33.3)540 (32.5)
Pulmonary hypertension, n(%)54 (0.0)320 (2.4)38 (3.4)147 (2.1)35 (1.7)34 (0.8)48 (0.8)185 (11.1)
  • Values are expressed as mean±SD or n (%).

  • BMI, body mass index; CAD, coronary artery disease; CHF, congestive heart failure; SBP, systolic blood pressure.